Back to Search
Start Over
Emmaus Life Sciences Reports 2022 Financial Results and Provides Business Update
- Source :
- Plus Financial Reports. April 3, 2023
- Publication Year :
- 2023
-
Abstract
- TORRANCE, Calif: Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported its results of operation for the year [...]
- Subjects :
- Sickle cell anemia
Company earnings/profit
Business
Endari (Medication)
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Financial Reports
- Publication Type :
- News
- Accession number :
- edsgcl.744748060